Posted by TSA West on March 12, 2002, at 23:28:27
In reply to Re: Eldepryl (selegiline) startup SEs + more » TSA West, posted by michael on March 12, 2002, at 21:33:53
I make the recommendation of other MAOIs because currently, there are no published data on the antidepressant efficacy of selegiline outside of Parkinson's Disease (http://www.acnp.org/g4/gn401000103/ch101.html) -- although this is clearly a reasonable avenue of investigation, according to the article.
I'm recommending the use of Isocarboxazid to people now because from what I've heard it has the efficacy of other MAOIs and a tolerability profile similar to the reversible Moclobemide.
poster:TSA West
thread:97558
URL: http://www.dr-bob.org/babble/20020307/msgs/97724.html